Health Care & Life Sciences » Pharmaceuticals | Grape King Bio Ltd.

Grape King Bio Ltd. | Cash Flow

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,427
1,689
1,883
2,312
2,405
2,427
Depreciation, Depletion & Amortization
123
127
150
209
225
256
Other Funds
-
3
399
340
422
475
Funds from Operations
1,347
1,539
1,725
2,191
2,149
2,208
Changes in Working Capital
232
169
101
225
75
10
Net Operating Cash Flow
1,579
1,708
1,826
2,415
2,223
2,218
Capital Expenditures
875
663
2,637
754
777
Sale of Fixed Assets & Businesses
-
-
3
-
1
Purchase/Sale of Investments
5
168
9
41
137
Net Investing Cash Flow
887
499
2,647
809
908
Cash Dividends Paid - Total
686
898
690
730
862
Issuance/Reduction of Debt, Net
3
7
2,483
446
190
Net Financing Cash Flow
692
905
1,393
1,516
1,566
Net Change in Cash
16
305
573
89
255
Free Cash Flow
704
1,056
808
1,679
1,451
Other Sources
1
-
-
-
5
Change in Capital Stock
-
-
-
-
91
Exchange Rate Effect
-
16
-
1
5
Other Uses
11
3
-
14
-

About Grape King Bio

View Profile
Address
No. 402, Section 2 Jinling Road
Taoyuan 324
Taiwan
Employees -
Website http://www.grapeking.com.tw
Updated 07/08/2019
Grape King Bio Ltd. engages in the manufacture and sale of health food products. It focuses on the mushroom mycelium and probiotics. Its business activities include preparation of pharmaceutical products, medicines, and raw materials; as well as the manufacture and trade of medical equipment.